The Future of Cellular Immunity Analysis

 Currently, a lot of strategies for cancer immunotherapy are undergoing clinical tests and trials. The final test for all the approaches used will be clinical efficacy. However, the tedious and complex pathway for these agents calls for an evaluation of immunological responses as interim indicators of the likely successful candidates.